ATE7785T1 - Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym- hemmende pharmazeutische zusammensetzung, die sie enthaelt. - Google Patents

Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym- hemmende pharmazeutische zusammensetzung, die sie enthaelt.

Info

Publication number
ATE7785T1
ATE7785T1 AT80104805T AT80104805T ATE7785T1 AT E7785 T1 ATE7785 T1 AT E7785T1 AT 80104805 T AT80104805 T AT 80104805T AT 80104805 T AT80104805 T AT 80104805T AT E7785 T1 ATE7785 T1 AT E7785T1
Authority
AT
Austria
Prior art keywords
latent
organic
enzyme
sulphoxydes
preparation
Prior art date
Application number
AT80104805T
Other languages
English (en)
Inventor
Raymond A. Firestone
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE7785T1 publication Critical patent/ATE7785T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymerisation Methods In General (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT80104805T 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym- hemmende pharmazeutische zusammensetzung, die sie enthaelt. ATE7785T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6660379A 1979-08-15 1979-08-15
EP80104805A EP0024639B1 (de) 1979-08-15 1980-08-14 Organische Sulphoxyde mit einer latenten Allyl-Gruppe, Verfahren zu deren Herstellung und Enzym-hemmende pharmazeutische Zusammensetzung, die sie enthält

Publications (1)

Publication Number Publication Date
ATE7785T1 true ATE7785T1 (de) 1984-06-15

Family

ID=22070551

Family Applications (4)

Application Number Title Priority Date Filing Date
AT80104806T ATE3545T1 (de) 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym hemmende pharmazeutische zusammensetzung, die sie enthaelt.
AT80104805T ATE7785T1 (de) 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym- hemmende pharmazeutische zusammensetzung, die sie enthaelt.
AT80104802T ATE5403T1 (de) 1979-08-15 1980-08-14 Organische sulfoxide, verfahren zu deren herstellung und diese enthaltende pharmazeutische enzym-blockierende zusammensetzungen.
AT80104803T ATE4316T1 (de) 1979-08-15 1980-08-14 Organische sulfoxide mit einer latenten allylgruppe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische antibakterielle zusammensetzung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT80104806T ATE3545T1 (de) 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym hemmende pharmazeutische zusammensetzung, die sie enthaelt.

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT80104802T ATE5403T1 (de) 1979-08-15 1980-08-14 Organische sulfoxide, verfahren zu deren herstellung und diese enthaltende pharmazeutische enzym-blockierende zusammensetzungen.
AT80104803T ATE4316T1 (de) 1979-08-15 1980-08-14 Organische sulfoxide mit einer latenten allylgruppe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische antibakterielle zusammensetzung.

Country Status (9)

Country Link
EP (4) EP0026307B1 (de)
JP (4) JPS5643260A (de)
AT (4) ATE3545T1 (de)
DE (4) DE3068110D1 (de)
DK (4) DK351080A (de)
ES (4) ES8106282A1 (de)
GR (4) GR69834B (de)
IE (4) IE50225B1 (de)
PT (4) PT71653B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
US4553191A (en) * 1982-12-03 1985-11-12 Xerox Corporation Static eliminator
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
DE3469169D1 (en) * 1983-04-21 1988-03-10 Merck Frosst Canada Inc Leukotriene antagonists, their production and use and compositions containing them
FR2661909B1 (fr) * 1990-05-09 1997-08-14 Inst Nat Sante Rech Med Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation.
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US6599938B1 (en) * 1999-10-29 2003-07-29 The Picower Institute Of Medical Research Compounds having MIF antagonist activity
JP5733856B2 (ja) 2007-10-09 2015-06-10 ソファーミア,インコーポレイテッド 広帯域β−ラクタマーゼ阻害薬
ES2700575T3 (es) 2013-03-12 2019-02-18 Gladius Pharmaceuticals Corp 3-Estiril-cefalosporinas derivadas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419606A (en) * 1964-05-13 1968-12-31 Merck & Co Inc 4-(2-methylenealkanoyl)phenylsulfinyl alkanoic acids
CH496639A (fr) * 1968-01-05 1970-09-30 Pfizer & Co C Procédé de préparation des aryl halogénocarbonyl cétènes
CH568708A5 (de) * 1969-04-30 1975-11-14 Hoffmann La Roche
GB1357154A (en) * 1970-09-25 1974-06-19 Shell Int Research Alkylthio-nitro-aniline compounds and herbicidal 'ompositions containing them
GB1463077A (en) * 1973-04-19 1977-02-02 Glaxo Lab Ltd 7-substituted-ethyl-cephalosporin derivatives
US4049806A (en) * 1975-08-15 1977-09-20 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
JPS5253890A (en) * 1975-10-14 1977-04-30 Syntex Inc Production of cephalosporin type compound
US4155907A (en) * 1976-08-16 1979-05-22 The Dow Chemical Company Method for inhibiting ADP-induced platelet aggregation using phenylthioalkylamines
JPS5350326A (en) * 1976-10-18 1978-05-08 Kao Corp Herbicides
AU4091178A (en) * 1977-10-25 1980-04-24 Merck & Co Inc Substituted mercapto acid amides

Also Published As

Publication number Publication date
PT71654A (en) 1980-09-01
JPS5643260A (en) 1981-04-21
ES494304A0 (es) 1981-08-01
EP0026307B1 (de) 1983-11-23
ATE3545T1 (de) 1983-06-15
DK351280A (da) 1981-02-16
PT71652A (en) 1980-09-01
PT71654B (en) 1982-01-22
ES8106283A1 (es) 1981-08-01
ES494302A0 (es) 1981-08-01
PT71653A (en) 1980-09-01
ES8106285A1 (es) 1981-08-01
DK351080A (da) 1981-02-16
PT71651A (en) 1980-09-01
EP0024347B1 (de) 1983-05-25
DE3065684D1 (en) 1983-12-29
ES8106284A1 (es) 1981-08-01
IE50225B1 (en) 1986-03-05
EP0026307A1 (de) 1981-04-08
EP0024639A1 (de) 1981-03-11
ES494305A0 (es) 1981-08-01
IE801708L (en) 1981-02-15
IE50152B1 (en) 1986-02-19
DE3068110D1 (en) 1984-07-12
EP0025857B1 (de) 1983-07-27
EP0024639B1 (de) 1984-06-06
JPS5663989A (en) 1981-05-30
PT71651B (en) 1982-01-21
IE50150B1 (en) 1986-02-19
ES8106282A1 (es) 1981-08-01
PT71652B (en) 1982-01-21
PT71653B (en) 1982-01-21
GR69833B (de) 1982-07-19
IE801707L (en) 1981-02-15
DK351180A (da) 1981-02-16
DE3063503D1 (en) 1983-07-07
GR69834B (de) 1982-07-19
DK350980A (da) 1981-02-16
DE3064411D1 (en) 1983-09-01
GR69805B (de) 1982-07-12
ES494303A0 (es) 1981-08-01
JPS5630960A (en) 1981-03-28
IE50151B1 (en) 1986-02-19
ATE4316T1 (de) 1983-08-15
IE801706L (en) 1981-02-15
JPS5630961A (en) 1981-03-28
EP0024347A1 (de) 1981-03-04
IE801705L (en) 1981-02-15
ATE5403T1 (de) 1983-12-15
GR69832B (de) 1982-07-19
EP0025857A1 (de) 1981-04-01

Similar Documents

Publication Publication Date Title
ATE9793T1 (de) 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT91602A (pt) Processo para a preparacao de compostos espiro com accao antibacteriana e de composicoes farmaceuticas que os contem
ATE7785T1 (de) Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym- hemmende pharmazeutische zusammensetzung, die sie enthaelt.
DE3882438D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE3542T1 (de) Als heilmittel verwendbare alcoxypropanolamine und verfahren zu ihrer herstellung.
ATE14124T1 (de) Ringfoermige sulfenamide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren herstellung.
BR8100539A (pt) Derivados de benzoxazolona,composicao fungicida ou bactericida contendo os mesmos,processo para sua preparacao bem como sua aplicacao
IL67464A (en) N,n-disubstituted alkenamides and phenylalkenamides,their production and pharmaceutical compositions containing them
ATE26712T1 (de) Phenyl-(3-aminopropyl)-keton-derivate, ihre therapeutische verwendung und verfahren zu ihrer herstellung.
SE8105628L (sv) Cefalosporinderivat
ATE4202T1 (de) Verfahren zur herstellung von pyrrol-2essigs[ureestern.